Business Description
Pacific Edge Limited is a New Zealand-based company focused on detecting and monitoring bladder cancer through urine-based genetic testing. Its flagship product, Cxbladder, is a non-invasive test that helps doctors determine whether patients are at risk of bladder cancer, reducing the need for uncomfortable and costly procedures. The company also has a broader pipeline of diagnostic tools in development targeting several other cancer types, including colorectal, gastric, and endometrial cancers. Founded in 2001 and headquartered in Dunedin, Pacific Edge aims to make cancer diagnosis faster, simpler, and less burdensome for patients.
